MorphImmune is a preclinical biotechnology company focused on developing targeted oncology therapeutics. The company's proprietary Targeted Effector platform selectively delivers payloads to diseased cells. The targeted approach reduces toxicity and increases efficacy of known effector molecules, ultimately improving outcomes for patients.
Company Details
- Employees
- 1
- Founded
- -
- Address
- 101 Foundry Dr, Suite 1200,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- morphimmune.com
- HQ
- West Lafayette, Indiana
Morphimmune Questions
Morphimmune's website is morphimmune.com
Morphimmune's LinkedIn profile is https://www.linkedin.com/company/morphimmune
Morphimmune has
1 employees.
View email and phone details for 1
employees at Morphimmune.
Morphimmune's industry is
Biotechnology Research
Morphimmune's top competitors are
Sudo Biosciences,
Seagen,
Tourmaline Bio,
Systimmune,
Umoja Biopharma,
Firefly Bio,
Oncoresponse,
Cogent Biosciences,
Sana Biotechnology, Inc.,
Immunome, Inc..
Morphimmune's categories are Biotechnology Research
Morphimmune's founding year is 2020
